| 缪伟刚,周金意,苏 健,等.2018年江苏省食管癌流行现状及2009—2018年变化趋势分析[J].中国肿瘤,2023,32(8):573-581. |
| 2018年江苏省食管癌流行现状及2009—2018年变化趋势分析 |
| Incidence and Mortality of Esophageal Carcinoma in 2018 and Trend of from 2009 to 2018 in Jiangsu Province |
| 投稿时间：2023-01-28 |
| DOI：10.11735/j.issn.1004-0242.2023.08.A002 |
|
 |
| 中文关键词: 食管癌 发病率 死亡率 江苏 |
| 英文关键词:esophageal carcinoma incidence mortality Jiangsu |
| 基金项目:中国消化道早癌医师共同成长计划科研项目（GTCZ-2022-JS-32-0001）；国家重点研发计划（2016YFC1302603）；江苏省卫生计生委医学科研课题（H201707） |
|
| 摘要点击次数: 860 |
| 全文下载次数: 306 |
| 中文摘要: |
| 摘 要：［目的］ 估算江苏省2018年食管癌发病和死亡状况，分析2009―2018年江苏省食管癌发病和死亡变化趋势。［方法］ 分城乡、性别和年龄组计算2018年江苏省48个经质控合格的肿瘤登记处食管癌发病率和死亡率，并结合2018年江苏省人口数据估算全省食管癌发病（死亡）数、粗率、年龄标准化率等指标。人口标准化参照Segi世界标准人口结构（世标率）和2000年中国标准人口结构（中标率）。采用Joinpoint回归模型计算江苏省16个经质控合格的肿瘤登记处2009―2018年食管癌发病中标率和死亡中标率平均年度变化百分比及其95%置信区间（CI）。［结果］ 2018年江苏省食管癌估计新发病例数25 202例，占江苏省全部恶性肿瘤新发病例的9.43%，位居恶性肿瘤发病谱第4位。食管癌粗发病率、中标率、世标率分别为32.22/10万、14.83/10万和17.21/10万。男性食管癌发病率高于女性（中标率：21.42/10万vs 8.49/10万），农村地区发病率高于城市地区（中标率：16.83/10万vs 12.56/10万）。2018年江苏省估计因食管癌死亡病例数21 636例，占江苏省全部恶性肿瘤死亡的12.89%，位居恶性肿瘤死亡谱第3位。食管癌粗死亡率、中标率、世标率分别为27.66/10万、12.15/10万和14.44/10万。男性死亡率高于女性（中标率：17.79 /10万vs 6.81/10万），农村地区死亡率高于城市地区（中标率：13.76 /10万 vs 10.30 /10万）。2009―2018年，江苏省食管癌中标发病率、中标死亡率平均每年分别下降6.14%（95%CI：-6.77%~-5.49%）和5.22%（95% CI：-5.82%~-4.62%），且无论城乡、男女性，食管癌中标发病率和中标死亡率变化趋势相同，均呈现整体下降趋势。［结论］ 近10年江苏省食管癌发病和死亡水平呈下降趋势，但其总体发病和死亡负担仍然较重，应继续加强食管癌综合防控措施，从而降低食管癌发病和死亡水平。 |
| 英文摘要: |
| Abstract：［Purpose］ To estimate the incidence and mortality rates of esophageal carcinoma in Jiangsu Province in 2018， and to investigate the trends from 2009 to 2018. ［Methods］ The qualified incidence and mortality data of esophageal carcinoma in 48 registries in Jiangsu Province were collected and stratified by area (urban or rural)， gender and age groups. The crude rates， age-standardized rates by Chinese standard population in 2000 (ASRC) and by world Segi’ s standard population (ASRW) were calculated. The Joinpoint regression model was used to calculate the average annual percentage change of the Chinese age-standardized incidence and mortality rates(ASIRC and ASMRC) in 16 registries in Jiangsu Province from 2009 to 2018. ［Results］ In 2018， there were estimated 25 202 new esophageal carcinoma cases in Jiangsu Province， accounted for 9.43% of total new cancer cases and ranked the 4th among all malignant tumors. The crude incidence rate， ASIRC and ASIRW were 32.22/105， 14.83/105 and 17.21/105， respectively. The ASIRC was higher in male than that in female(21.42/105 vs 8.49/105)； the ASIRC was higher in rural areas than that in urban areas(16.83/105 vs 12.56/105). The estimated deaths of esophageal carcinoma were 21 636 in Jiangsu Province in 2018， accounted for 12.89% of all cancer deaths and ranked the 3rd of all malignant tumors. The crude mortality rate， ASMRC and ASMRW were 27.66/105， 12.15/105 and 14.44/105， respectively. The ASMRC was higher in males than that in female(17.79/105 vs 6.81/105)； the ASMRC was higher in rural areas than that in urban areas (13.76/105 vs 10.30/105). From 2009 to 2018， the annual ASIRC and ASMRC decreased by 6.14% ［95% confidence interval(CI)： -6.77%~-5.49%］ and 5.22%(95%CI： -5.82%~-4.62%)， which showed the same downward trend in urban and rural areas， in male and female. ［Conclusion］ Both incidence and mortality rates of esophageal carcinoma demonstrate significant downtrends in Jiangsu Province from 2009 to 2008. However， the overall burdens of incidence and mortality remain high. The comprehensive prevention and control measures of esophageal carcinoma should be enhanced to reduce the incidence and death levels of esophageal carcinoma. |
|
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |